Home › Aldermeesklierkanker › Florida › Tampa
Aldermeesklierkanker klinische studies in Tampa, FL
26 studies voor Aldermeesklierkanker zoeken deelnemers op locaties in en rond Tampa (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RekruterenFase 3
- Moffitt Cancer Center, Tampa
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruterenFase 1
- Moffitt Cancer Center, Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RekruterenObservatieonderzoek
- Moffitt Cancer Center, Tampa
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruterenFase 1/2
- Moffitt Cancer Center, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruterenFase 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekruterenFase 1/2
- Moffitt Cancer Center, Tampa
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer
Rekruteren
- Moffitt Cancer Center, Tampa
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
RekruterenFase 3
- Moffitt Cancer Center, Tampa
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekruterenFase 2
- Moffitt Cancer Center, Tampa
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekruterenFase 3
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens
Rekruteren
- Moffitt Cancer Center, Tampa
Pancreatic Cancer Early Detection Consortium
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Moffitt Cancer Center, Tampa
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RekruterenFase 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruterenFase 1/2
- Moffitt Cancer Center, Tampa
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
RekruterenFase 1
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekruterenFase 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekruterenFase 1
- Lee Moffitt Cancer Center, Tampa
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RekruterenFase 1/2
- Moffitt Cancer Center, Tampa
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
RekruterenFase 3
- Moffitt Cancer Center - McKinley Campus, Tampa
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekruterenFase 2
- Ohio State University-Telemedicine, Tampa
A First-in-Human Study of FID-022 in Solid Tumor Patients
RekruterenObservatieonderzoek
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #16, Tampa
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RekruterenFase 1
- H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
RekruterenFase 1/2
- Tampa General Hospital, Tampa
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
RekruterenObservatieonderzoek
- University of South Florida, Tampa
Aldermeesklierkanker studies in andere steden
- Houston, TX61 studies
- New York City, NY60 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Durham, NC24 studies
- San Diego, CA24 studies
Andere studies in Tampa
- Niet-kleincellige longkanker51 studies
- Borstkanker43 studies
- Kanker (alle vormen)39 studies
- Colorectale kanker34 studies
- Acute myeloïde leukemie29 studies
- Metastatische kanker29 studies
- Longkanker29 studies
- Eierstokkanker21 studies
- Melanoom19 studies
- Myelodysplastische syndromen19 studies
- Prostaatkanker18 studies
- Hartfalen18 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.